Literature DB >> 9692821

Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.

R J Strege1, W Saeger, R P Linke.   

Abstract

Fourty-three cases of systemic amyloidosis were identified in an unselected autopsy series from our institute (6305 autopsies between 1979 and 1993) and classified immunohistochemically by means of a panel of antisera directed against five major amyloid fibril proteins. Amyloid A (AA) amyloidosis was the most common type, being found in 21 cases (48.8%). Transthyretin-derived (ATTR) amyloidosis was present in 11 cases (25.6%), and immunoglobulin light chain-derived (AL) amyloidosis in 10 cases (23.3%). A single case (2.3%) contained deposits of more than one type of systemic amyloid. AA amyloidosis was associated with chronic inflammatory or infectious diseases (81%), malignant tumours (19%) or both (9.5%). Immunoglobulin light chain-derived amyloidoses were associated with myeloma (50%) or primary (idiopathic; 50%). In AA and AL amyloidosis the kidney was the organ most frequently involved. ATTR amyloid affecting mostly the heart and lungs presented as senile systemic amyloidosis. Systemic amyloidosis was the cause of death in 5 cases (12%) and caused symptoms in 17 cases (39%). Our results suggest that most cases can be classified by using a panel of sensitive and specific antibodies against five major amyloid fibril proteins. This technique may make amyloid type-specific therapy possible for AL amyloid patients who do not have evidence of an underlying plasma cell dyscrasia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692821     DOI: 10.1007/s004280050211

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.

Authors:  T Liu; B Zhang; X Jin; W Wang; J Lee; J Li; H Yuan; X Cheng
Journal:  Eye (Lond)       Date:  2013-10-11       Impact factor: 3.775

2.  Amyloid in endomyocardial biopsies.

Authors:  Barbara Kieninger; Magdalena Eriksson; Reinhard Kandolf; Philipp A Schnabel; Stefan Schönland; Arnt V Kristen; Ute Hegenbart; Peter Lohse; Christoph Röcken
Journal:  Virchows Arch       Date:  2010-04-08       Impact factor: 4.064

3.  Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

Authors:  B Stix; T Kähne; K Sletten; J Raynes; A Roessner; C Röcken
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.

Authors:  Michael G Fradley; Joseph V Thakuria; A Bernard Collins; Stephanie A Moore; James R Stone
Journal:  Tex Heart Inst J       Date:  2012

5.  Stiff heart syndrome.

Authors:  Satya S Bhupathi; Sreelatha Chalasani; Roxann Rokey
Journal:  Clin Med Res       Date:  2010-09-17

Review 6.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 7.  Waldenström's macroglobulinemia associated with AA amyloidosis.

Authors:  J Gardyn; A Schwartz; R Gal; U Lewinski; D Kristt; A M Cohen
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

8.  Renal amyloidosis in Behçet's disease: clinicopathologic features of 8 cases.

Authors:  Kemal Kosemehmetoglu; Dilek Ertoy Baydar
Journal:  Int Urol Nephrol       Date:  2012-09-09       Impact factor: 2.370

9.  An unusual case of cardiac amyloidosis.

Authors:  Brian Garibaldi; David Zaas
Journal:  J Gen Intern Med       Date:  2007-04-20       Impact factor: 5.128

10.  [Amyloidosis in liver biopsies].

Authors:  Z Gioeva; B Kieninger; C Röcken
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.